Thalassemia is a genetic blood disorder characterized by a very low production of hemoglobin which causes anemia. Hemoglobin is found in the red blood cells and carries oxygen throughout the body. The low levels of hemoglobin result into a low circulation of oxygen hence affecting the function of different organs.

Common treatments includes many times routine blood transfusions and other therapies.The treatment of Thalassemia through Iron Chelation therapy requires an adjustable infusion profile depending on the patient's weight, height and conditions e.g. levels of Iron in the blood. Usually, an infusion needs around 10-12 hours to complete so the use of the right ambulatory infusion pump allows the patient to really have a normal life by being fully mobile during infusion.

Alternatively, the MP mlh+ and the MP 101+ syringe drivers can be used for Thalassemia treatment, to address different infusion profile needs.

Freedom without clinical compromise